Research Study
Alzheimer’s Disease and patient recruitment
Patient enrolment is proving to be particularly challenging for sponsors conducting clinical research in earlier stages of Alzheimer’s disease. Higher patient numbers, challenging screening criteria and the burden of work required is resulting in slow enrolment rates at sites.
Attempting to meet this challenge through opening more and more sites in a wider range of territories is inefficient, costly, risky in terms of data consistency and is failing.
Read how one sponsor is changing the paradigm and is experiencing a dramatic improvement in patient enrolment in this Therapeutic Area.
